Turnstone Biologics Corp.
TSBXDelisted Aug 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764974
Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Turnstone Biologics Corp. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 23 | 1 | −22 |
| Shares | 8.43M | 40.4K | −8.39M (−99.5%) |
| Value | $3.03M | $0 | −$3.03M (−100.0%) |
New holders (0)
Institutions that held Turnstone Biologics Corp. at the end of Q3 2025 but not at the end of Q2 2025.
None.
Sold out (22)
Institutions that held Turnstone Biologics Corp. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| OrbiMed Advisors LLC | 3,099,265 | $1.11M |
| FMR LLC | 1,133,987 | $407.1K |
| BML Capital Management, LLC | 1,103,386 | $396.1K |
| Takeda Pharmaceutical Co Ltd | 895,824 | $321.6K |
| Point72 Asset Management, L.P. | 816,923 | $293.3K |
| 72 Investment Holdings, LLC | 549,980 | $197.4K |
| Citadel Advisors LLC | 208,887 | $75.0K |
| Geode Capital Management, LLC | 130,077 | $46.7K |
| Deltec Asset Management LLC | 106,057 | $38.1K |
| Vanguard Group Inc | 83,926 | $30.1K |
| Susquehanna International Group, LLP | 79,305 | $28.5K |
| HRT Financial LP | 55,859 | $20.0K |
| Renaissance Technologies LLC | 47,100 | $16.9K |
| GTS Securities LLC | 45,163 | $16.2K |
| Northern Trust Corp | 18,405 | $6.61K |
| Acadian Asset Management LLC | 16,430 | $4.00K |
| Tower Research Capital LLC (TRC) | 4,741 | $1.70K |
| BlackRock, Inc. | 1,066 | $383 |
| JPMorgan Chase & Co | 158 | $57 |
| Bank of America Corp | 150 | $54 |
| BNP Paribas Arbitrage, SA | 121 | $43 |
| UBS Group AG | 71 | $25 |